Table of Content

Executive Summary
1 Product Definition

2 Scope of Work
2.1 Report Coverage
2.2 Exclusions and Inclusion Criteria of the Report
2.2.1 Exclusion Criteria
2.2.2 Inclusion Criteria
2.3 Key Questions Answered in the Report

3 Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Data Sources Categorization
3.5 Companies Profiled in the Report
3.6 Assumptions and Limitations

4 Industry Analysis
4.1 Industry Structure
4.1.1 Virtual Diagnostics Vendors
4.1.2 Contract Manufacturers
4.1.3 Distributors
4.2 Legal & Regulatory Framework
4.2.1 North America
4.2.1.1 Regulatory Requirements in the U.S.
4.2.1.2 Regulatory Requirements in Canada
4.2.2 Europe
4.2.3 Other Countries
4.3 Associations, Consortiums, and Regulatory Bodies
4.4 Patent Analysis
4.4.1 Patent Filing Trend, January 2015 to December 2019
4.4.2 Awaited Technologies

5 Competitive Landscape
5.1 Overview
5.2 Key Strategies and Developments
5.2.1 Regulatory and Legal Activities
5.2.2 Partnerships, Alliances, Agreements, and Business Expansions
5.2.3 New Offerings
5.2.4 Funding Activities
5.3 Growth Share Analysis
5.3.1 Growth Share Matrix (by Type of Diagnosis)
5.3.2 Growth Share Matrix (by End User)
5.3.3 Growth Share Matrix (by Region)
5.4 Product Mapping Analysis

6 Global Virtual Diagnostics Market Scenario
6.1 Limitations and Assumptions
6.2 Key Findings
6.3 Global Virtual Diagnostics Market and Forecast (2019-2030)
6.3.1 Market Drivers
6.3.1.1 Advancements in Application of Biosensor Technology
6.3.1.2 Rising Gastrointestinal Disorders
6.3.1.3 Technological Breakthroughs in Diagnostic Testing Techniques
6.3.1.4 Increasing Demand for Smartphone-Based Diagnostics
6.3.1.5 High Accessibility to Remote Areas
6.3.1.6 Increasing Awareness in Disease Diagnostics
6.3.1.7 Improved Microscopic Imaging in Smartphones
6.3.2 Market Restraints
6.3.2.1 Hindrance in Privacy through Virtual Diagnostic Methods
6.3.2.2 Risk of Low Accuracy in Diagnosis
6.3.3 Market Opportunities
6.3.3.1 Large Scope of Cross Vertical Collaboration
6.3.3.2 Strong Pipeline of Virtual Diagnostic Products and Platforms

7 Global Virtual Diagnostics Market (by Type of Diagnosis)
7.1 Overview
7.2 Gastrointestinal Virtual Diagnostics Market
7.3 Ophthalmology Virtual Diagnostics Market
7.4 Cardiology Virtual Diagnostics Market
7.5 Pathology Virtual Diagnostics Market
7.6 Others Virtual Diagnostics Market

8 Global Virtual Diagnostics Market (by End User)
8.1 Overview
8.2 Hospitals
8.3 Specialty Clinics and Ambulatory Surgical Centers
8.4 Others (Homecare and Research Institutes)

9 Global Virtual Diagnostics Market (by Region)
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 Australia
9.4.4 South Korea
9.4.5 India
9.4.6 Rest-of-Asia-Pacific
9.5 Latin America, Middle East, and Africa

10 Company Profiles
10.1 AliveCor Inc.
10.1.1 Company Overview
10.1.2 Role of Alivecor, Inc. in the Global Virtual Diagnostics Market
10.1.3 SWOT Analysis
10.2 Cardiologs Technologies
10.2.1 Company Overview
10.2.2 Role of Cardiologs Technologies in the Global Virtual Diagnostics Market
10.2.3 SWOT Analysis
10.3 CapsoVision, Inc.
10.3.1 Company Overview
10.3.2 Role of CapsoVision, Inc. in the Global Virtual Diagnostics Market
10.3.3 SWOT Analysis
10.4 Eyenuk, Inc.
10.4.1 Company Overview
10.4.2 Role of Eyenuk Inc. in the Global Virtual Diagnostics Market
10.4.3 SWOT Analysis
10.5 Healthy.io Ltd.
10.5.1 Company Overview
10.5.2 Role of Healthy.io Ltd. in the Global Virtual Diagnostics Market
10.5.3 SWOT Analysis
10.6 hearX IP (Pty) Ltd.
10.6.1 Company Overview
10.6.2 Role of hearX IP (Pty) Ltd. in the Global Virtual Diagnostics Market
10.6.3 SWOT Analysis
10.7 Hill-Rom Holdings, Inc.
10.7.1 Company Overview
10.7.2 Role of Hill-Rom Holdings, Inc in the Global Virtual Diagnostics Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 IDx Technologies Inc.
10.8.1 Company Overview
10.8.2 Role of IDx Technologies Inc. in the Global Virtual Diagnostics Market
10.8.3 SWOT Analysis
10.9 Medtronic Plc.
10.9.1 Company Overview
10.9.2 Role of Medtronic Plc. in the Global Virtual Diagnostics Market
10.9.3 Financials
10.9.4 SWOT Analysis
10.10 Monitored Therapeutics Inc.
10.10.1 Company Overview
10.10.2 Role of Monitored Therapeutics Inc. in the Global Virtual Diagnostics Market
10.10.3 SWOT Analysis
10.11 Olympus Corporation
10.11.1 Company Overview
10.11.2 Role of Olympus Corporation in the Global Virtual Diagnostics Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12 Phelcom Technologies
10.12.1 Company Overview
10.12.2 Role of Phelcom Technologies in the Global Virtual Diagnostics Market
10.12.3 SWOT Analysis
10.13 ResApp Health Limited
10.13.1 Company Overview
10.13.2 Role of ResApp Health Limited in the Global Virtual Diagnostics Market
10.13.3 SWOT Analysis
10.14 Sight Diagnostics
10.14.1 Company Overview
10.14.2 Role of Sight Diagnostics in the Global Virtual Diagnostics Market
10.14.3 SWOT Analysis
10.15 SkinVision
10.15.1 Company Overview
10.15.2 Role of SkinVision in the Global Virtual Diagnostics Market
10.15.3 SWOT Analysis

List of Tables

Table 4.1: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment and Headquarters
Table 5.1: Company Product Mapping Analysis
Table 6.1: Impact of Market Drivers, 2019-2030
Table 6.2: Impact of Market Restraints, 2019-2030

List of Figures

Figure 1: Global Virtual Diagnostics Market Growth, 2018-2030
Figure 2: Impact Analysis for Key Market Drivers and Restraints, 2019-2030
Figure 3: Share of Key Developments and Strategies, January 2016-January 2020
Figure 4: Global Virtual Diagnostics Market (by Region), 2018-2030
Figure 5: Global Virtual Diagnostics Market (by Type of Diagnosis and by End User), 2018 and 2030
Figure 2.1: Global Virtual Diagnostics Market Segmentation
Figure 3.1: Global Virtual Diagnostics Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Shares of Key Companies Profiled
Figure 3.5: Assumptions and Limitations
Figure 4.1: Number of Patents Filed, January 2015 to December 2019
Figure 5.1: Share of Key Developments and Strategies, January 2016 to January 2020
Figure 5.2: Analysis of Key Developmental Strategies, by Year, January 2016 to January 2020
Figure 5.3: Regulatory and Legal (By Company), January 2016 to January 2020
Figure 5.4: Partnerships, Alliances, and Business Expansions (by Company), January 2016 to January 2020
Figure 5.5: New Offerings (by Company), January 2016 to January 2020
Figure 5.6: Funding Activities (by Company), January 2016 to January 2020
Figure 5.7: Growth Share Matrix for Global Virtual Diagnostics Market (by Type of Diagnosis), 2019-2030
Figure 5.8: Growth Share Matrix for Global Virtual Diagnostics Market (by End User), 2019-2030
Figure 5.9: Growth Share Matrix for Global Virtual Diagnostics Market (by Region), 2019-2030
Figure 6.1: Global Virtual Diagnostics Market Incremental Growth Opportunity, 2018-2030
Figure 7.1: Global Virtual Diagnostics Market Share (by Type of Diagnosis), 2018 and 2030
Figure 7.2: Global Virtual Diagnostics Market (by Type of Diagnosis), 2018-2030
Figure 7.3: Global Gastrointestinal Virtual Diagnostics Market, 2018-2030
Figure 7.4: Global Ophthalmology Virtual Diagnostics Market, 2018-2030
Figure 7.5: Global Cardiology Virtual Diagnostics Market, 2018-2030
Figure 7.6: Global Pathology Virtual Diagnostics Market, 2018-2030
Figure 7.7: Global Virtual Diagnostics Market for Others Segment, 2018-2030
Figure 8.1: Global Virtual Diagnostics Market Share (by End User), 2018 and 2030
Figure 8.2: Global Virtual Diagnostics Market (by End User), 2018-2030
Figure 8.3: Global Virtual Diagnostics Market for Hospital Segment, 2018-2030
Figure 8.4: Global Virtual Diagnostics Market for Speciality Clinics and Ambulatory Surgical Centers, 2018-2030
Figure 8.5: Global Virtual Diagnostics Market for Others Segment, 2018-2030
Figure 9.1: Global Virtual Diagnostics Market (by Region), 2018-2030
Figure 9.2: North America Virtual Diagnostics Market Share (by Country), 2018 and 2030
Figure 9.3: North America Virtual Diagnostics Market, 2018-2030
Figure 9.4: North America: Market Dynamics
Figure 9.5: U.S. Virtual Diagnostics Market, 2018-2030
Figure 9.6: Canada Virtual Diagnostics Market, 2018-2030
Figure 9.7: Europe Virtual Diagnostics Market Share (by Country), 2018 and 2030
Figure 9.8: Europe Virtual Diagnostics Market, 2018-2030
Figure 9.9: Europe: Market Dynamics
Figure 9.10: Germany Virtual Diagnostics Market, 2018-2030
Figure 9.11: France Virtual Diagnostics Market, 2018-2030
Figure 9.12: U.K. Virtual Diagnostics Market, 2018-2030
Figure 9.13: Italy Virtual Diagnostics Market, 2018-2030
Figure 9.14: Spain Virtual Diagnostics Market, 2018-2030
Figure 9.15: Rest-of-Europe Virtual Diagnostics Market, 2018-2030
Figure 9.16: Asia-Pacific Virtual Diagnostics Market Share (by Country), 2018 and 2030
Figure 9.17: Asia-Pacific Virtual Diagnostics Market,2018-2030
Figure 9.18: Asia-Pacific: Market Dynamics
Figure 9.19: Japan Virtual Diagnostics Market, 2018-2030
Figure 9.20: China Virtual Diagnostics Market, 2018-2030
Figure 9.21: Australia Virtual Diagnostics Market, 2018-2030
Figure 9.22: South Korea Virtual Diagnostics Market, 2018-2030
Figure 9.23: India Virtual Diagnostics Market, 2018-2030
Figure 9.24: Rest of Asia-Pacific Virtual Diagnostics Market, 2018-2030
Figure 9.25: Latin America, Middle East, and Africa Virtual Diagnostics Market, 2018-2030
Figure 9.26: Middle East, Latin America, Middle East, and Africa: Market Dynamics
Figure 10.1: AliveCor, Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.2: AliveCor, Inc.: SWOT Analysis
Figure 10.3: Cardiologs Technologies: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.4: Cardiologs Technologies: SWOT Analysis
Figure 10.5: CapsoVision Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.6: CapsoVision, Inc.: SWOT Analysis
Figure 10.7: Eyenuk Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.8: Eyenuk Inc.: SWOT Analysis
Figure 10.9: Healthy.io Ltd.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.10: Healthy.io. Ltd.: SWOT Analysis
Figure 10.11: hearX IP (Pty) Ltd.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.12: hearX IP (Pty) Ltd.: SWOT Analysis
Figure 10.13: Hill-Rom Holdings, Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.14: Hill-Rom Holdings, Inc.: Overall Financials, 2017-2019
Figure 10.15: Hill-Rom Holdings, Inc.: Revenue (by Segment), 2017-2019
Figure 10.16: Hill-Rom Holdings, Inc.: Revenue (by Region), 2017-2019
Figure 10.17: Hill-Rom Holdings, Inc.: R&D Expenditure, 2017-2019
Figure 10.18: Hill-Rom Holdings, Inc.: SWOT Analysis
Figure 10.19: IDx Technologies Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.20: IDx Technologies Inc.: SWOT Analysis
Figure 10.21: Medtronic Plc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.22: Medtronic Plc: Overall Financials, 2017-2019
Figure 10.23: Medtronic Plc: Revenue (by Segment), 2017-2019
Figure 10.24: Medtronic Plc: Revenue (by Region), 2017-2019
Figure 10.25: Medtronic Plc: R&D Expenditure, 2017-2019
Figure 10.26: Medtronic Plc.: SWOT Analysis
Figure 10.27: Monitored Therapeutics Inc.: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.28: Monitored Therapeutics, Inc.: SWOT Analysis
Figure 10.29: Olympus Corporation: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.30: Olympus Corporation: Overall Financials, 2016-2018
Figure 10.31: Olympus Corporation: Revenue (by Segment), 2016-2018
Figure 10.32: Olympus Corporation: Revenue (by Region), 2016-2018
Figure 10.33: Olympus Corporation: R&D Expenditure, 2016-2018
Figure 10.34: Olympus Corporation: SWOT Analysis
Figure 10.35: Phelcom Technologies: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.36: Phelcom Technologies: SWOT Analysis
Figure 10.37: ResApp Health Limited: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.38: ResApp Health Limited: SWOT Analysis
Figure 10.39: Sight Diagnostics: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.40: Sight Diagnostics: SWOT Analysis
Figure 10.41: SkinVision: Product Portfolio for Global Virtual Diagnostics Market
Figure 10.42: SkinVision: SWOT Analysis